Norepinephrine salt formulations are not a matter of pharmacologic potency
- PMID: 38695929
- DOI: 10.1007/s00134-024-07451-2
Norepinephrine salt formulations are not a matter of pharmacologic potency
References
-
- Kattan E, Ibarra-Estrada M, Jung C (2024) Knowing the ropes of vasopressor dosing: a focus on norepinephrine. Intensive Care Med. https://doi.org/10.1007/s00134-024-07374-y - DOI - PubMed - PMC
-
- Wieruszewski PM, Leone M, Kaas-Hansen BS et al (2024) Position paper on the reporting of norepinephrine formulations in critical care from the society of critical care medicine and european society of intensive care medicine joint task force. Crit Care Med 52:521–530. https://doi.org/10.1097/CCM.0000000000006176 - DOI - PubMed
-
- Kenakin T, Williams M (2014) Defining and characterizing drug/compound function. Biochem Pharmacol 87:40–63. https://doi.org/10.1016/j.bcp.2013.07.033 - DOI - PubMed
-
- Currigan DA, Hughes RJA, Wright CE et al (2014) Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries: an in vitro study. Anesthesiology 121:930–936. https://doi.org/10.1097/ALN.0000000000000430 - DOI - PubMed
-
- Wieruszewski PM (2023) Norepinephrine dosage: the details go beyond a grain of salt. Intensive Care Med 49:714–715. https://doi.org/10.1007/s00134-023-07077-w - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
